Agios Pharmaceuticals
AGIO
AGIO
189 hedge funds and large institutions have $2.01B invested in Agios Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 73 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
34% less capital invested
Capital invested by funds: $3.03B → $2.01B (-$1.02B)
75% less call options, than puts
Call options by funds: $8.62M | Put options by funds: $35.1M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
189
Holding in Top 10
–
Calls
$8.62M
Puts
$35.1M
Top Buyers
| 1 | +$44.4M | |
| 2 | +$27.3M | |
| 3 | +$14.4M | |
| 4 |
CC
Casdin Capital
New York
|
+$14.3M |
| 5 |
CII
Capital International Inc
Los Angeles,
California
|
+$10.3M |
Top Sellers
| 1 | -$47M | |
| 2 | -$23.9M | |
| 3 | -$16M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$11.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.92M |